Negotiations involve smaller drug manufacturers.
Meetings are taking place with the White House.
Tariffs are influencing pricing strategies.
Briefing: Small Drugmakers Negotiate Pricing Deals Amid Tariff Threat
Strategic angle: The Trump administration is in talks with smaller pharmaceutical companies to establish new drug-pricing agreements.